|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-11-5
|
|
pubmed:abstractText |
A weekly continuous 24-hour infusion therapy with 5-fluorouracil (5-FU) and calcium - folinic acid (CA-FA) was shown to be an effective first-line treatment in advanced metastatic colorectal cancer. Sodium - folinic acid (S-FA) is a new formulation which, in contrast to CA-FA allows the simultaneous i.v. administration in combination with 5-FU in one pump.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0378-584X
|
|
pubmed:author |
pubmed-author:DreesMM,
pubmed-author:FritzeDD,
pubmed-author:HartungGG,
pubmed-author:HehlmannRR,
pubmed-author:HofheinzR DRD,
pubmed-author:KühnelJJ,
pubmed-author:KreuserE DED,
pubmed-author:QueisserWW,
pubmed-author:RiedelCC,
pubmed-author:RosePP,
pubmed-author:WeilCC
|
|
pubmed:copyrightInfo |
Copyright 2001 S. Karger GmbH, Freiburg
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
457-62
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11694772-Adult,
pubmed-meshheading:11694772-Aged,
pubmed-meshheading:11694772-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11694772-Colorectal Neoplasms,
pubmed-meshheading:11694772-Drug Administration Schedule,
pubmed-meshheading:11694772-Female,
pubmed-meshheading:11694772-Fluorouracil,
pubmed-meshheading:11694772-Follow-Up Studies,
pubmed-meshheading:11694772-Humans,
pubmed-meshheading:11694772-Infusions, Intravenous,
pubmed-meshheading:11694772-Leucovorin,
pubmed-meshheading:11694772-Male,
pubmed-meshheading:11694772-Middle Aged,
pubmed-meshheading:11694772-Neoplasm Staging,
pubmed-meshheading:11694772-Sodium,
pubmed-meshheading:11694772-Survival Rate
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer.
|
|
pubmed:affiliation |
Onkologisches Zentrum, III. Medizinische Klinik, Universitätsklinikum Mannheim der Universität Heidelberg, Mannheim. Gernot.Hartung@med.uni-rostock.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
